mannitol has been researched along with devazepide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arnold, R; Bauer, C; Lauer, G; Mönnikes, H; Tebbe, J; Zittel, TT | 1 |
| Hulce, M; Reidelberger, RD; Woltman, TA | 1 |
3 other study(ies) available for mannitol and devazepide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pathways of Fos expression in locus ceruleus, dorsal vagal complex, and PVN in response to intestinal lipid.
Topics: Animals; Benzodiazepinones; Capsaicin; Cerebral Ventricles; Cholecystokinin; Devazepide; Duodenum; Enteral Nutrition; Fat Emulsions, Intravenous; Gene Expression Regulation; Hormone Antagonists; Locus Coeruleus; Male; Mannitol; Paraventricular Hypothalamic Nucleus; Phenylurea Compounds; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Solitary Nucleus; Vagus Nerve | 1997 |
Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats.
Topics: Anesthesia; Animals; Antipyrine; Antiviral Agents; Blood-Brain Barrier; Cerebellum; Devazepide; Diuretics, Osmotic; Hormone Antagonists; Male; Mannitol; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin | 1999 |